Papers: 10.1007/s00280-018-3738-x

https://doi.org/10.1007/s00280-018-3738-x

A phase II trial of the effect of perindopril on hand–foot skin reaction (HFSR) incidence and severity in patients receiving regorafenib for refractory mCRC

Cited by: 3
Author(s): Barbara Melosky, Howard John Lim, Janine Marie Davies, Sharlene Gill, Christian Kollmannsberger, Maria Yi Ho, Solomon A. Vandt, Daniel J. Renouf
Published: almost 8 years ago

Software Mentions 1